Patient-reported Outcomes (PRO) and Treatment Outcomes of Chinese Patients With MSS-type Advanced Colorectal Cancer Who Received the Zidovudine Combination Regimen in the Real World
RecruitingOBSERVATIONAL
Enrollment
300
Participants
Timeline
Start Date
July 10, 2025
Primary Completion Date
July 30, 2026
Study Completion Date
July 30, 2027
Conditions
Colorectal Cancer
Trial Locations (1)
827153
RECRUITING
West China Hospital Sichuan University, Chengdu
All Listed Sponsors
lead
West China Hospital
OTHER
NCT07105631 - Patient-reported Outcomes (PRO) and Treatment Outcomes of Chinese Patients With MSS-type Advanced Colorectal Cancer Who Received the Zidovudine Combination Regimen in the Real World | Biotech Hunter | Biotech Hunter